Un estudio para investigar la seguridad y tolerabilidad a largo plazo de itepekimab en participantes con EPOC (AERIFY-4)
Un estudio de extensión doble ciego para evaluar la seguridad y tolerabilidad a largo plazo de itepekimab en pacientes con enfermedad pulmonar obstructiva crónica (EPOC) que participaron en los estudios clínicos EFC16750 o EFC16819
This is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide additional PK and immunogenicity assessments.
The primary purpose of this study is to evaluate safety and tolerability of both itepekimab SC Q2W or itepekimab SC Q4W in participants with COPD having completed the treatment period of the clinical studies EFC16750 or EFC16819. A secondary purpose of this study is to provide efficacy outcomes beyond the treatment period of the parent trials EFC16750 and EFC16819.
Study details include:
- The study duration will be up to 72 weeks
- The treatment duration will be up to 52 weeks
- A follow-up period of 20 weeks will be conducted
- The number of on-site visits will be 7 and the number of phone contacts will be 5
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Fase
Fase
- Fase 3
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Bendorf, Alemania, 56170
- Investigational Site Number : 2760006
-
Berlin, Alemania, 12159
- Investigational Site Number : 2760010
-
Frankfurt, Alemania, 60596
- Investigational Site Number : 2760005
-
Leipzig, Alemania, 04299
- Investigational Site Number : 2760008
-
Leipzig, Alemania, 04347
- Investigational Site Number : 2760007
-
Lübeck, Alemania, 23552
- Investigational Site Number : 2760003
-
Mainz, Alemania, 55128
- Investigational Site Number : 2760001
-
Rosenheim, Alemania, 83022
- Investigational Site Number : 2760011
-
-
-
-
-
Buenos Aires, Argentina, 1425
- Investigational Site Number : 0320002
-
Buenos Aires, Argentina, 1023
- Investigational Site Number : 0320010
-
Buenos Aires, Argentina, 1414
- Investigational Site Number : 0320005
-
Buenos Aires, Argentina, 1638
- Investigational Site Number : 0320006
-
Buenos Aires, Argentina, 1650
- Investigational Site Number : 0320009
-
Mendoza, Argentina, 5500
- Investigational Site Number : 0320004
-
-
Buenos Aires
-
Berazategui, Buenos Aires, Argentina, 1886
- Investigational Site Number : 0320012
-
La Plata, Buenos Aires, Argentina, B1900BNN
- Investigational Site Number : 0320013
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, 2000
- Investigational Site Number : 0320007
-
Rosario, Santa Fe Province, Argentina, 2000
- Investigational Site Number : 0320003
-
Rosario, Santa Fe Province, Argentina, 2000
- Investigational Site Number : 0320008
-
Rosario, Santa Fe Province, Argentina, 2000
- Investigational Site Number : 0320011
-
-
-
-
-
São Paulo, Brasil, 04014-002
- Núcleo de Pesquisa Clínica da Rede São Camilo- Site Number : 0760013
-
-
Espírito Santo
-
Vitória, Espírito Santo, Brasil, 29055-450
- Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760009
-
-
Estado de Bahia
-
Salvador, Estado de Bahia, Brasil, 40150-150
- Serviços Especializados em Reumatologia- Site Number : 0760020
-
-
Federal District
-
Brasília, Federal District, Brasil, 70710-100
- Centro De Cardiologia Clinica E Pesquisa- Site Number : 0760018
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brasil, 30150-221
- Santa Casa de Misericordia de Belo Horizonte- Site Number : 0760014
-
-
Paraná
-
Curitiba, Paraná, Brasil, 80030-110
- Centro de Estudos em Terapias Inovadoras- Site Number : 0760012
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasil, 90020-090
- Irmandade da Santa Casa de Misericórdia de Porto Alegre- Site Number : 0760001
-
Porto Alegre, Rio Grande do Sul, Brasil, 90480-020
- Instituto Ceos Site Number : 0760021
-
Porto Alegre, Rio Grande do Sul, Brasil, 90610-000
- Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760007
-
Porto Alegre, Rio Grande do Sul, Brasil, 91010-006
- WM Pesquisas Clínicas em Doenças Respiratórias- Site Number : 0760006
-
-
São Paulo
-
Botucatu, São Paulo, Brasil, 18618-970
- Universidade Estadual Paulista - Faculdade de Medicina de Botucatu- Site Number : 0760005
-
Campinas, São Paulo, Brasil, 13034-685
- Hospital e Maternidade Celso Pierro - PUC-Campinas- Site Number : 0760010
-
São Bernardo do Campo, São Paulo, Brasil, 09715-090
- Centro Multidisciplinar de Estudos Clínicos- Site Number : 0760015
-
-
-
-
-
Gabrovo, Bulgaria, 5300
- Investigational Site Number : 1000004
-
Haskovo, Bulgaria, 6300
- Investigational Site Number : 1000007
-
Rousse, Bulgaria, 7000
- Investigational Site Number : 1000018
-
Rousse, Bulgaria, 7002
- Investigational Site Number : 1000010
-
Sofia, Bulgaria, 1233
- Investigational Site Number : 1000001
-
Sofia, Bulgaria, 1756
- Investigational Site Number : 1000009
-
Sofia, Bulgaria, 1142
- Investigational Site Number : 1000016
-
Stara Zagora, Bulgaria, 6000
- Investigational Site Number : 1000017
-
Stara Zagora, Bulgaria, 6003
- Investigational Site Number : 1000003
-
Veliko Tarnovo, Bulgaria, 5000
- Investigational Site Number : 1000013
-
Vidin, Bulgaria, 3700
- Investigational Site Number : 1000006
-
-
-
-
Alberta
-
Sherwood Park, Alberta, Canadá, T8H 0N2
- Investigational Site Number : 1240006
-
-
Ontario
-
Ajax, Ontario, Canadá, L1S 2J5
- Investigational Site Number : 1240021
-
Toronto, Ontario, Canadá, M5T 3A9
- Investigational Site Number : 1240009
-
Windsor, Ontario, Canadá, N8X 1T3
- Investigational Site Number : 1240022
-
Windsor, Ontario, Canadá, N8X 5A6
- Investigational Site Number : 1240018
-
-
Quebec
-
Sherbrooke, Quebec, Canadá, J1H 5N4
- Investigational Site Number : 1240004
-
Trois-Rivières, Quebec, Canadá, G8T 7A1
- Investigational Site Number : 1240001
-
Victoriaville, Quebec, Canadá, G6P 3Z8
- Investigational Site Number : 1240002
-
-
-
-
-
Havlíčkův Brod, Chequia, 580 01
- Investigational Site Number : 2030003
-
Jindřichův Hradec, Chequia, 377 01
- Investigational Site Number : 2030001
-
-
-
-
Los Ríos Region
-
Valdivia, Los Ríos Region, Chile, 5110683
- Investigational Site Number : 1520008
-
-
Maule Region
-
Talca, Maule Region, Chile, 3465584
- Investigational Site Number : 1520006
-
-
Reg Metropolitana de Santiago
-
Santiago, Reg Metropolitana de Santiago, Chile, 7500010
- Investigational Site Number : 1520007
-
Santiago, Reg Metropolitana de Santiago, Chile, 7500692
- Investigational Site Number : 1520001
-
Santiago, Reg Metropolitana de Santiago, Chile, 7500698
- Investigational Site Number : 1520003
-
Santiago, Reg Metropolitana de Santiago, Chile, 7750000
- Investigational Site Number : 1520002
-
-
Valparaiso
-
Quillota, Valparaiso, Chile, 2260877
- Investigational Site Number : 1520005
-
-
-
-
Gangwon-do
-
Wŏnju, Gangwon-do, Corea del Sur, 26426
- Investigational Site Number : 4100002
-
-
Seoul-teukbyeolsi
-
Seoul, Seoul-teukbyeolsi, Corea del Sur, 05030
- Investigational Site Number : 4100001
-
-
-
-
-
Humenné, Eslovaquia, 066 01
- Investigational Site Number : 7030002
-
Prešov, Eslovaquia, 080 01
- Investigational Site Number : 7030004
-
Spišská Nová Ves, Eslovaquia, 052 01
- Investigational Site Number : 7030003
-
-
-
-
-
Madrid, España, 28007
- Investigational Site Number : 7240003
-
Madrid, España, 28040
- Investigational Site Number : 7240007
-
Málaga, España, 29010
- Investigational Site Number : 7240001
-
Palma, España, 07120
- Investigational Site Number : 7240004
-
Zaragoza, España, 50009
- Investigational Site Number : 7240012
-
-
Barcelona [Barcelona]
-
Barcelona, Barcelona [Barcelona], España, 08017
- Investigational Site Number : 7240014
-
-
Catalunya [Cataluña]
-
Sant Boi de Llobregat, Catalunya [Cataluña], España, 08830
- Investigational Site Number : 7240006
-
-
Madrid
-
Pozuelo de Alarcón, Madrid, España, 28223
- Investigational Site Number : 7240008
-
-
-
-
Arizona
-
Chandler, Arizona, Estados Unidos, 85224
- Chandler Clinical Research Trials- Site Number : 8401034
-
Tucson, Arizona, Estados Unidos, 85704
- Noble Clinical Research Site Number : 8401182
-
Tucson, Arizona, Estados Unidos, 85712
- Tucson Clinical Research Institute- Site Number : 8401431
-
-
California
-
La Palma, California, Estados Unidos, 90623
- IMAX Clinical Trials- Site Number : 8401419
-
Lancaster, California, Estados Unidos, 93534
- Antelope Valley Clinical Trials Site Number : 8401003
-
Los Angeles, California, Estados Unidos, 90017
- Downtown L.A. Research Center- Site Number : 8401027
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80014
- Allianz Research Institute CO Site Number : 8402061
-
Boulder, Colorado, Estados Unidos, 80301
- Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8401180
-
-
Florida
-
Boynton Beach, Florida, Estados Unidos, 33435
- Helix Biomedics- Site Number : 8402049
-
Cutler Bay, Florida, Estados Unidos, 33157
- Beautiful Minds Clinical Research Center Site Number : 8401201
-
DeBary, Florida, Estados Unidos, 32713
- Omega Research Consultants - Debary - North Charles Richard Beall Boulevard- Site Number : 8402031
-
Doral, Florida, Estados Unidos, 33178
- Science Connections, LLC Site Number : 8402045
-
Hialeah, Florida, Estados Unidos, 33012
- Direct Helpers Research Center- Site Number : 8402065
-
Lady Lake, Florida, Estados Unidos, 32159
- Premier Medical Associates Site Number : 8401388
-
Loxahatchee Groves, Florida, Estados Unidos, 33470
- Advanced Pulmonary Research Institute Site Number : 8402018
-
Miami, Florida, Estados Unidos, 33126
- Finlay Medical Research- Site Number : 8402007
-
Miami, Florida, Estados Unidos, 33144
- Elite Clinical Research - Miami- Site Number : 8402009
-
Miami, Florida, Estados Unidos, 33155
- DL Research Solutions- Site Number : 8401033
-
Miami, Florida, Estados Unidos, 33155
- My Community Research Center Site Number : 8402060
-
Miami, Florida, Estados Unidos, 33165
- Phoenix Medical Research - Miami - 24th Street- Site Number : 8402019
-
Miami, Florida, Estados Unidos, 33173
- Research Institute of South Florida- Site Number : 8401006
-
Miami, Florida, Estados Unidos, 33176
- Reed Medical Research Site Number : 8401032
-
Miami, Florida, Estados Unidos, 33184
- High Quality Research Site Number : 8401406
-
Miami Lakes, Florida, Estados Unidos, 33014
- Deluxe Health Center Site Number : 8401188
-
Ocala, Florida, Estados Unidos, 34470
- Renstar Medical Research - Ocala - Northeast 1st Avenue- Site Number : 8402015
-
Orlando, Florida, Estados Unidos, 32819
- Heuer M.D. Research- Site Number : 8402016
-
Orlando, Florida, Estados Unidos, 32825
- Florida Institute for Clinical Research Site Number : 8401013
-
Oviedo, Florida, Estados Unidos, 32765
- Oviedo Medical Research Site Number : 8402026
-
Palmetto Bay, Florida, Estados Unidos, 33157
- Innovation Medical Research Center - Palmetto Bay- Site Number : 8402067
-
Pembroke Pines, Florida, Estados Unidos, 33024
- Pines Care Research Center- Site Number : 8402056
-
Pembroke Pines, Florida, Estados Unidos, 33025
- Tellabio International Research Services Site Number : 8401411
-
Tampa, Florida, Estados Unidos, 33606
- Clinical Research of West Florida - Tampa - North Howard Avenue- Site Number : 8402008
-
-
Georgia
-
Calhoun, Georgia, Estados Unidos, 30701
- Appalachian Clinical Research Site Number : 8400024
-
Cordele, Georgia, Estados Unidos, 31015
- Private Practice - Dr. David Kavtaradze- Site Number : 8401029
-
Dunwoody, Georgia, Estados Unidos, 30350
- Alpha Clinical Research Group - Dunwoody- Site Number : 8401190
-
East Point, Georgia, Estados Unidos, 30344
- Covenant Pulmonary Critical Care Site Number : 8401183
-
-
Illinois
-
Peoria, Illinois, Estados Unidos, 61637
- OSF Saint Fracis Medical Center- Site Number : 8402024
-
-
Louisiana
-
Covington, Louisiana, Estados Unidos, 70433
- Benchmark Research - Covington- Site Number : 8401193
-
Shreveport, Louisiana, Estados Unidos, 71105
- Care Access - Shreveport- Site Number : 8402047
-
-
Maine
-
Bangor, Maine, Estados Unidos, 04401
- Private Practice - Dr. Paul Shapero- Site Number : 8401016
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02110
- Care Access - Boston- Site Number : 8402276
-
-
Michigan
-
Lathrup Village, Michigan, Estados Unidos, 48076
- Revive Research Institute - Lathrup Village- Site Number : 8402186
-
Warren, Michigan, Estados Unidos, 48088
- Pulmonary and Medicine Associates- Site Number : 8401403
-
-
Missouri
-
Hannibal, Missouri, Estados Unidos, 63401-6890
- Hannibal Regional Healthcare System-HRMG-Hannibal Site Number : 8401383
-
Saint Charles, Missouri, Estados Unidos, 63301
- Midwest Chest Consultants- Site Number : 8401002
-
St Louis, Missouri, Estados Unidos, 63110
- Washington University- Site Number : 8402035
-
-
Nevada
-
Henderson, Nevada, Estados Unidos, 89052
- Henderson Clinical Trials Site Number : 8401365
-
-
New York
-
Buffalo, New York, Estados Unidos, 14215
- VA Western New York Healthcare System Site Number : 8402050
-
Schenectady, New York, Estados Unidos, 12308
- Schenectady Pulmonary and Critical Care Associates - Schenectady Main Office- Site Number : 8402029
-
-
North Carolina
-
Greenville, North Carolina, Estados Unidos, 27858
- East Carolina University- Site Number : 8401022
-
Huntersville, North Carolina, Estados Unidos, 28078
- Advanced Respiratory and Sleep Medicine - Huntersville- Site Number : 8400022
-
-
Oklahoma
-
Edmond, Oklahoma, Estados Unidos, 73034
- OK Clinical Research- Site Number : 8402001
-
-
Pennsylvania
-
DuBois, Pennsylvania, Estados Unidos, 15801
- Clinical Research Associates of Central PA - Dubois- Site Number : 8401023
-
Pittsburgh, Pennsylvania, Estados Unidos, 15212
- Allegheny General Hospital- Site Number : 8402058
-
-
South Carolina
-
Columbia, South Carolina, Estados Unidos, 29204
- MedTrial- Site Number : 8402048
-
Rock Hill, South Carolina, Estados Unidos, 29732
- Clinical Research of Rock Hill Site Number : 8401008
-
-
Texas
-
Beaumont, Texas, Estados Unidos, 77701
- REX Clinical Trials - Beaumont- Site Number : 8401371
-
Boerne, Texas, Estados Unidos, 78006
- South Texas Medical Research Institute - TTS Research- Site Number : 8402012
-
Carrollton, Texas, Estados Unidos, 75007
- ClinRx Research - Carrollton- Site Number : 8401021
-
Corsicana, Texas, Estados Unidos, 75110
- Corsicana Medical Research- Site Number : 8401018
-
Houston, Texas, Estados Unidos, 77030
- The Methodist Hospital Research Institute Site Number : 8401194
-
McKinney, Texas, Estados Unidos, 75069
- Metroplex Pulmonary and Sleep Center Site Number : 8401015
-
Webster, Texas, Estados Unidos, 77598
- Clear Lake Specialties Research Center, PLLC Site Number : 8401025
-
-
West Virginia
-
Beckley, West Virginia, Estados Unidos, 25801
- Rheumatology & Pulmonary Clinic- Site Number : 8402053
-
-
-
-
-
Tartu, Estonia, 50406
- Investigational Site Number : 2330001
-
-
-
-
-
Lyon, Francia, 69004
- Investigational Site Number : 2500001
-
Reims, Francia, 51092
- Investigational Site Number : 2500004
-
-
-
-
-
Batumi, Georgia, 6010
- Investigational Site Number : 2680006
-
Tbilisi, Georgia, 0112
- Investigational Site Number : 2680003
-
Tbilisi, Georgia, 0105
- Investigational Site Number : 2680002
-
Tbilisi, Georgia, 0159
- Investigational Site Number : 2680001
-
-
-
-
-
Palaió Fáliro, Grecia, 175 62
- Investigational Site Number : 3000008
-
Thessaloniki, Grecia, 570 10
- Investigational Site Number : 3000002
-
-
-
-
-
Budapest, Hungría, 1106
- Investigational Site Number : 3480009
-
Gödöllő, Hungría, 2100
- Investigational Site Number : 3480001
-
Hajdúnánás, Hungría, 4080
- Investigational Site Number : 3480004
-
Mosonmagyaróvár, Hungría, 9200
- Investigational Site Number : 3480002
-
Püspökladány, Hungría, 4150
- Investigational Site Number : 3480003
-
-
-
-
-
Calicut, India, 673008
- Investigational Site Number : 3560001
-
Chandigarh, India, 160012
- Investigational Site Number : 3560006
-
Hyderabad, India, 500 084
- Investigational Site Number : 3560005
-
Jaipur, India, 302039
- Investigational Site Number : 3560004
-
Jaipur, India, 302023
- Investigational Site Number : 3560009
-
Kanpur, India, 208001
- Investigational Site Number : 3560012
-
Nagpur, India, 441203
- Investigational Site Number : 3560003
-
Nagpur, India, 440010
- Investigational Site Number : 3560010
-
Nagpur, India, 440012
- Investigational Site Number : 3560011
-
Nagpur, India, 440015
- Investigational Site Number : 3560007
-
Pune, India, 411057
- Investigational Site Number : 3560013
-
-
-
-
-
Haifa, Israel, 3436212
- Investigational Site Number : 3760008
-
Jerusalem, Israel, 9103102
- Investigational Site Number : 3760003
-
Jerusalem, Israel, 9112001
- Investigational Site Number : 3760002
-
Kefar Sava, Israel, 4428164
- Investigational Site Number : 3760006
-
Petah Tikva, Israel, 4941492
- Investigational Site Number : 3760001
-
Ramat Gan, Israel, 5262100
- Investigational Site Number : 3760009
-
Rehovot, Israel, 7610001
- Investigational Site Number : 3760004
-
Tel Aviv, Israel, 6423906
- Investigational Site Number : 3760007
-
-
-
-
-
Ferrara, Italia, 44100
- Investigational Site Number : 3800001
-
-
-
-
-
Fukuoka, Japón, 819-0055
- Investigational Site Number : 3920003
-
Tokyo, Japón, 140-8522
- Investigational Site Number : 3920004
-
-
Aichi-ken
-
Nagoya, Aichi-ken, Japón, 457-8511
- Investigational Site Number : 3920008
-
-
Fukuoka
-
Kurume, Fukuoka, Japón, 830-0011
- Investigational Site Number : 3920002
-
-
Hiroshima
-
Kure, Hiroshima, Japón, 737-0811
- Investigational Site Number : 3920007
-
-
Hyōgo
-
Himeji, Hyōgo, Japón, 670-0849
- Investigational Site Number : 3920006
-
-
Kanagawa
-
Yokohama, Kanagawa, Japón, 234-0054
- Investigational Site Number : 3920009
-
-
Mie-ken
-
Matsusaka, Mie-ken, Japón, 515-0073
- Investigational Site Number : 3920001
-
-
Tokyo
-
Kiyose, Tokyo, Japón, 204-8522
- Investigational Site Number : 3920005
-
-
-
-
-
Kaunas, Lituania, 49449
- Investigational Site Number : 4400002
-
-
-
-
-
Durango, México, 34000
- Investigational Site Number : 4840007
-
-
-
-
-
Lørenskog, Noruega, 1478
- Investigational Site Number : 5780001
-
-
-
-
-
Breda, Países Bajos, 4818 CK
- Investigational Site Number : 5280001
-
-
-
-
Podlaskie Voivodeship
-
Bialystok, Podlaskie Voivodeship, Polonia, 15-044
- Investigational Site Number : 6160001
-
-
Świętokrzyskie Voivodeship
-
Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship, Polonia, 27-400
- Investigational Site Number : 6160002
-
-
-
-
-
Beijing, Porcelana, 100038
- Investigational Site Number : 1560012
-
Changchun, Porcelana, 130021
- Investigational Site Number : 1560004
-
Chengdu, Porcelana, 610041
- Investigational Site Number : 1560001
-
Haikou, Porcelana, 570216
- Investigational Site Number : 1560018
-
Hefei, Porcelana, 230032
- Investigational Site Number : 1560016
-
Hohhot, Porcelana, 010050
- Investigational Site Number : 1560017
-
Jinan, Porcelana, 250014
- Investigational Site Number : 1560002
-
Nanchang, Porcelana, 330006
- Investigational Site Number : 1560014
-
Pingxiang, Porcelana, 337055
- Investigational Site Number : 1560019
-
Shanghai, Porcelana, 200025
- Investigational Site Number : 1560020
-
Shanghai, Porcelana, 200433
- Investigational Site Number : 1560006
-
Shenyang, Porcelana, 110004
- Investigational Site Number : 1560008
-
Wuhan, Porcelana, 430014
- Investigational Site Number : 1560005
-
Xiangtan, Porcelana, 411100
- Investigational Site Number : 1560011
-
Xuzhou, Porcelana, 221006
- Investigational Site Number : 1560007
-
Yangzhou, Porcelana, 225000
- Investigational Site Number : 1560015
-
-
-
-
-
Porto, Portugal, 3814-501
- Investigational Site Number : 6200006
-
-
-
-
-
Bradford, Reino Unido, BD9 6RJ
- Investigational Site Number : 8260003
-
Hounslow, Reino Unido, TW5 9ER
- Investigational Site Number : 8260014
-
Liverpool, Reino Unido, L14 3PE
- Investigational Site Number : 8260005
-
London, Reino Unido, EC1M 6BQ
- Investigational Site Number : 8260010
-
Milton Keynes, Reino Unido, MK15 0DU
- Investigational Site Number : 8260008
-
-
Hampshire
-
Portsmouth, Hampshire, Reino Unido, PO6 3LY
- Investigational Site Number : 8260004
-
-
Surrey
-
Chertsey, Surrey, Reino Unido, KT16 0PZ
- Investigational Site Number : 8260002
-
-
-
-
-
Cluj-Napoca, Rumania, 400275
- Investigational Site Number : 6420002
-
-
-
-
-
Benoni, Sudáfrica, 1500
- Investigational Site Number : 7100004
-
Durban, Sudáfrica, 4001
- Investigational Site Number : 7100001
-
Durban, Sudáfrica, 4001
- Investigational Site Number : 7100006
-
Durban, Sudáfrica, 4302
- Investigational Site Number : 7100005
-
-
-
-
-
Kaohsiung City, Taiwán, 807
- Investigational Site Number : 1580005
-
Taichung, Taiwán, 404
- Investigational Site Number : 1580006
-
Taipei, Taiwán, 110
- Investigational Site Number : 1580003
-
-
-
-
-
Akdeniz, Turquía (Türkiye), 33070
- Investigational Site Number : 7920002
-
Ankara, Turquía (Türkiye), 06230
- Investigational Site Number : 7920007
-
Istanbul, Turquía (Türkiye), 34098
- Investigational Site Number : 7920001
-
Kirikkale, Turquía (Türkiye), 71100
- Investigational Site Number : 7920006
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients with COPD who completed the treatment period in a previous itepekimab COPD Phase 3 clinical study (ie, EFC16750 or EFC16819) and for which an end-of-treatment (EOT) visit occurred no later than 3 days before the enrolment visit of this study.
Exclusion Criteria:
- Diagnosis of a malignancy during parent study, except a squamous or basal cell carcinoma of the skin
- Any opportunistic infection during the parent study, such as tuberculosis (TB) or other infections whose nature or course may suggest an immunocompromised status
- Anaphylactic reactions or systemic allergic reactions that are related to IMP and require treatment during the parent study
- Any situation that led to a permanent premature IMP discontinuation in parent trials
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Triple
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: Itepekimab Q2W
Subcutaneous (SC) administration of Itepekimab every 2 weeks (Q2W) for up to 52 weeks |
Pharmaceutical form:solution for injection in pre-filled syringe Route of administration:subcutaneous
Otros nombres:
|
|
Experimental: Itepekimab Q4W
SC administration of Itepekimab every 4 weeks (Q4W) for up to 52 weeks, with alternating SC administration of matching placebo at the 2-week interval between active IMP |
Pharmaceutical form:solution for injection in pre-filled syringe Route of administration:subcutaneous
Otros nombres:
Pharmaceutical form:solution for injection in pre-filled syringe Route of administration:subcutaneous |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Incidence of treatment-emergent AEs, AESIs, SAEs, and AEs leading to permanent treatment discontinuation
Periodo de tiempo: Baseline up to Week 72
|
All AEs (serious or nonserious) will be collected from the signing of the informed consent form (ICF) until the end of study visit |
Baseline up to Week 72
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Concentraciones funcionales de itepekimab en suero.
Periodo de tiempo: Línea de base hasta la semana 52
|
Línea de base hasta la semana 52
|
|
|
Tasa anualizada de AECOPD grave
Periodo de tiempo: Línea de base hasta la semana 52
|
Línea de base hasta la semana 52
|
|
|
Tiempo hasta la primera AECOPD de moderada a grave
Periodo de tiempo: Línea de base hasta la semana 52
|
Línea de base hasta la semana 52
|
|
|
Tiempo hasta la primera AECOPD grave
Periodo de tiempo: Línea de base hasta la semana 52
|
Línea de base hasta la semana 52
|
|
|
Incidencia de respuestas de anticuerpos antidrogas emergentes (TE)
Periodo de tiempo: Línea de base hasta la semana 72
|
Línea de base hasta la semana 72
|
|
|
Tasa anualizada de exacerbación aguda de moderada a severa de la EPOC (AECOPD)
Periodo de tiempo: Línea de base hasta la semana 52
|
Línea de base hasta la semana 52
|
|
|
Change from baseline of the parent studies (EFC16750, EFC16819): Pre-BD and post-BD FEV1
Periodo de tiempo: Baseline of the parent studies (EFC16750,EFC16819) up to Week 52
|
FEV1 is force expiratory volume in 1 second |
Baseline of the parent studies (EFC16750,EFC16819) up to Week 52
|
|
Change from baseline of the parent studies (EFC16750, EFC16819): SGRQ total score and domain scores
Periodo de tiempo: Baseline of the parent studies (EFC16750,EFC16819) up to Week 52
|
The St. George's Respiratory Questionnaire (SGRQ) is a 50-item questionnaire designed to measure and quantify health status in adult participants with chronic airflow limitation. |
Baseline of the parent studies (EFC16750,EFC16819) up to Week 52
|
|
Change from baseline of the parent studies (EFC16750, EFC16819): EQ-5D-5L single index score
Periodo de tiempo: Baseline of the parent studies (EFC16750,EFC16819) up to Week 52
|
The European Quality of Life 5 Dimensions 5 Level Version (EQ 5D 5L) is a standardized health-related quality-of-life (HRQoL) questionnaire which consists of a descriptive system and the EuroQol visual analog scale (EQ-VAS). |
Baseline of the parent studies (EFC16750,EFC16819) up to Week 52
|
|
Change from baseline of the parent studies (EFC16750, EFC16819): EQ-VAS
Periodo de tiempo: Baseline of the parent studies (EFC16750,EFC16819) up to Week 52
|
The EuroQol visual analog scale (EQ VAS) records the participant's self-rated health on a vertical VAS. |
Baseline of the parent studies (EFC16750,EFC16819) up to Week 52
|
|
Change from Week 0 for CASA-Q
Periodo de tiempo: Baseline up to Week 52
|
The cough and sputum assessment questionnaire (CASA-Q) was developed for use in COPD and chronic (non-obstructive) bronchitis patients. |
Baseline up to Week 52
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Director de estudio: Clinical Sciences & Operations, Sanofi
Publicaciones y enlaces útiles
Enlaces Útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Actual)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- LTS18133
- U1111-1295-3333 (Identificador de registro: ICTRP)
- 2023-508085-15-00 (Identificador de registro: CTIS)
- 2023 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://vivli.org
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .